Jadbio

JADBio Accelerates Biomarker Discovery using AutoML, a machine learning tool that automates biomarker discovery without coding. It employs automated machine learning to analyze the function of biomarkers based on particular research goals.

This tool is available through the AWS Marketplace. By using technology to improve the discovery process, it can speed up the process of discovering drugs and lower the associated expenses.

The platform is capable of analyzing a variety of multi-omics data types, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images. This feature enables researchers to rapidly and effectively extract insights relevant to their studies.

The tool has found use in areas such as initial biomarker discovery, drug repurposing, and understanding how individuals respond to treatments. Additionally, the tool's no-code machine learning feature allows users to automate the biomarker discovery process specific to their research objectives.

To assist researchers in getting started with the platform, the company offers a comprehensive array of support resources, including case studies, webinars, and a glossary.

JADBio is also in partnership with reputable organizations such as Indivumed, QIAGEN, Ledidi, BioLizard, and Elucidata. To begin utilizing the tool, researchers have the option to register for a complimentary JADBio AutoML account.